Fukushima, Japan

Takeshi Nara

This inventor holds 1 USPTO granted patent. Top assignees: Sagami Chemical Research Center, Toa Eiyo Ltd.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeshi Nara. Retrieved from https://idiyas.com/inventor/takeshi-nara-ouspit9y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Takeshi Nara

Introduction

Takeshi Nara is a notable inventor based in Fukushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prostacyclin analogues. His work focuses on improving blood circulation through innovative chemical compounds.

Latest Patents

Takeshi Nara holds a patent for a prostacyclin analogue and blood circulation improving agent. The patent describes a complex chemical formula that includes various substituents and configurations aimed at enhancing the efficacy of blood circulation treatments. This innovation represents a step forward in therapeutic options for patients with circulatory issues.

Career Highlights

Throughout his career, Nara has worked with prominent organizations such as Sagami Chemical Research Center and Toa Eiyo Ltd. His experience in these companies has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Masakatsu Shibasaki and Atsuo Takahashi. Their collaborative efforts have likely played a role in advancing the research and development of innovative medical solutions.

Conclusion

Takeshi Nara's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence advancements in medical treatments for blood circulation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…